Dr. Kris Kasireddy is the Founder and President of DSK Biopharma, Inc., leading the company’s research and development operations since its inception in 2014. With over two decades of experience in organic and medicinal chemistry, Dr. Kasireddy brings extensive scientific expertise and strategic insight to the organization.
Prior to founding DSK Biopharma, Dr. Kasireddy served as the Founder and Vice President of HDH Pharma (2008–2014), where he successfully directed numerous custom synthesis and medicinal chemistry projects. Earlier in his career, he worked with NeoPharm, where his contributions to sRNA-based drug delivery technologies earned him the Employee of the Year Award in 2005.
Dr. Kasireddy’s academic background includes postdoctoral research at the University of Arizona and the University of North Texas. He obtained his Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology (IICT), Hyderabad, India.
An accomplished scientist, Dr. Kasireddy has authored and co-authored more than 30 research publications and patents in reputed international journals. His leadership continues to drive DSK Biopharma’s commitment to innovation, quality, and customer satisfaction.
20+ Years Experience
- Dr. Kasi Reddy contributed to the development of sRNA-based drug delivery technologies during his employment at Neo Pharm and achieved employee of the year award in 2005.
- Dr. Kasi Reddy received his PhD in organic chemistry from Indian Institute of Chemical Technology, Hyderabad, India.
- Dr. Kasi Reddy, to his credit published more than 30 publications and patents in international journals.